Improved methods for determining binding affinities
Details for Australian Patent Application No. 2002365252 (hide)
International Classifications
Event Publications
7 August 2003 Complete Application Filed
Priority application(s): 60/355,534 08.02.02 US; 60/316,147 30.08.01 US
4 September 2003 Application Open to Public Inspection
Published as AU-B-2002365252
22 February 2007 Application Accepted
Published as AU-B-2002365252
21 June 2007 Standard Patent Sealed
21 June 2007 Corrigenda
Applications Accepted - Name Index Under the names Scott Klakamp and David Myszka, Application No. 2002365252, under INID (72) insert co-inventor Klakamp, Scott. Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the AU-A or AU-B CD-ROM of this Journal date. 2001275371 PowderJect Vaccines, Inc. 2002231519 Zedgas Inc. 2002313965 Corus Technology BV 2002348043 Kohler Co. 2002348853 Tazi, E.H.
26 March 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002365253-Glycoconjugate vaccines for use in immune-compromised populations
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser